Dr. Yaqin Wu | Carcinoma | Women Researcher Award

Dr. Yaqin Wu | Carcinoma | Women Researcher Award

Hunan provincial people’s hospital | China

AUTHOR PROFILE

Scopus

🌟Wu Yaqin 

🏥CURRENT ROLES AND AFFILIATIONS 

  • Current Position: Organizational Committee Member, Graduate Student Party Branch
  • Graduate Institution: Hunan Provincial People’s Hospital (Hunan Normal University First Affiliated Hospital), Breast and Thyroid Surgery, Master’s Supervisor: Professor Zhang Chaojie
  • Undergraduate Institution: Hunan Normal University Medical School, Clinical Medicine (2014.9–2019.6)

📚EARLY ACADEMIC PURSUITS 

Wu Yaqin began her academic journey at Hunan Normal University Medical School, excelling in Clinical Medicine. Her undergraduate years were marked by stellar academic performance, with scholarships awarded every year, including National Scholarship and National Inspirational Scholarship.

🔬PROFESSIONAL ENDEAVORS 

Currently pursuing a Master’s degree in Surgery (Breast and Thyroid Surgery) at Hunan Provincial People’s Hospital, Wu has honed her clinical and research skills. She has gained recognition for:

  1. Outstanding clinical rotation performance.
  2. Active participation in surgeries, assisting in level 3 and 4 operations.
  3. Representing her hospital in Clinical Skills Competitions.

🧪CONTRIBUTIONS AND RESEARCH FOCUS 

Wu Yaqin has a strong foundation in research and innovation, focusing on:

  • Scientific Techniques: Proficiency in WB, PCR, single-cell sequencing, metabolomics, and other experimental skills.
  • Data Analysis: Skilled in SPSS, bioinformatics, and advanced statistical analysis.
  • Publications:
    • 2 SCI papers as the first and corresponding author (Cumulative Impact Factor: 5.143).
    • 2 core journal publications in China.
  • Research Projects:
    • Contributed to two provincial-level projects and two horizontal projects as the lead researcher (under mentor guidance).

🌟IMPACT AND INFLUENCE 

Wu’s contributions extend beyond academia:

  • Regularly earns recognition as an Outstanding Party Member, Student, and Graduate.
  • Actively involved in expert consensus compilation, adding to professional guidelines.
  • Participates in large-scale event organization with exceptional planning and execution skills.

PERSONAL SKILLS AND INTERESTS 🎙️

  • Language Proficiency:
    • Passed CET-4 and CET-6.
    • Achieved Grade 2-A in the National Mandarin Test.
  • Technical Skills:
    • Proficient in basic and advanced experimental techniques.
    • Skilled in computer applications (provincial-level certification).
  • Special Interests: Broadcasting, hosting, debate, and recitation.

RECOGNITION AND HONORS 🏅

During Master’s Program:

  • Authored high-impact research papers.
  • Contributed to prestigious projects and received multiple awards for academic excellence.

During Undergraduate Program:

  • Awarded numerous scholarships and honors.
  • Served in various leadership roles:
    • Vice Minister, Learning Department of the Student Union.
    • Captain, Debate Team.
    • Psychological Committee Member, Class Representative.

LEGACY AND FUTURE CONTRIBUTIONS 🌐

Wu Yaqin’s dedication to clinical excellence, innovative research, and effective communication positions her as a rising star in medical sciences. She is committed to:

  1. Advancing clinical practice and surgical expertise.
  2. Expanding her impact through cutting-edge research and mentorship roles.
  3. Building a legacy of leadership and service within the medical community.

 

📊🔬NOTABLE PUBLICATION:
  • 1. LncRNA SNHG5 promotes the glycolysis and proliferation of breast cancer cell through regulating BACH1 via targeting miR-299
    • Authors: Huang, S.-L., Huang, Z.-C., Zhang, C.-J., Wu, Y.-Q., Fan, P.-Z.
    • Journal: Breast Cancer
    • Year: 2022

    2. The expression and meaning of CD68, CD163, CD57, and IgG4 in granulomatous lobular mastitis

    • Authors: Kong, C., Zhang, C., Wu, Y., He, J., Fan, P.
    • Journal: Gland Surgery
    • Year: 2020

    3. miRNA-195-5p/PSAT1 feedback loop in human triple-negative breast cancer cells

    • Authors: Wang, H., Fang, Q., You, S., Wu, Y., Zhang, C.
    • Journal: Genes and Genomics
    • Year: 2023

    4. Value of dissection of lymph nodes posterior to the right recurrent laryngeal nerve in patients with cN0 papillary thyroid carcinoma

    • Authors: Xiao, X., Wu, Y., Zou, L., Chen, Y., Zhang, C.
    • Journal: Gland Surgery
    • Year: 2022

    5. A clinical observation of stage I implant breast reconstruction for mass-like granulomatous lobular mastitis

    • Authors: Zhang, C., Wu, Y., Wang, H., Li, Q., Fan, P.
    • Journal: Gland Surgery
    • Year: 2021

Dr. Na Wang | Chemotherapy | Best Researcher Award

Dr. Na Wang | Chemotherapy | Best Researcher Award

First Affiliated Hospital of Xi’an Jiaotong University | China

AUTHOR PROFILE

Scopus

📘 DR. NA WANG, DEPARTMENT OF RESPIRATORY AND CRITICAL CARE MEDICINE, FIRST AFFILIATED HOSPITAL OF XI’AN JIAOTONG UNIVERSITY

🏫 EARLY ACADEMIC PURSUITS

Dr. Na Wang embarked on a distinguished academic journey, laying a strong foundation in respiratory medicine and critical care. She pursued her medical degree with a focus on respiratory health, demonstrating exceptional dedication and a commitment to addressing complex medical challenges. Her postgraduate studies were marked by advanced training in pulmonology, where she honed her expertise in the diagnosis and management of respiratory diseases.


🏥 PROFESSIONAL ENDEAVORS

Currently serving at the First Affiliated Hospital of Xi’an Jiaotong University, Dr. Wang plays a pivotal role in the Department of Respiratory and Critical Care Medicine. She has contributed significantly to clinical care, focusing on Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) and the broader spectrum of critical care management. Dr. Wang is recognized for her ability to translate complex clinical scenarios into innovative therapeutic strategies, improving patient outcomes.


🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CHEMOTHERAPY

Dr. Wang’s research is centered on Chronic Obstructive Pulmonary Disease (COPD), particularly its acute exacerbations, which are leading causes of hospitalization and mortality worldwide. Her studies delve into:

  • The pathophysiological mechanisms underlying AECOPD.
  • Biomarker identification for early diagnosis and prognosis.
  • Innovative therapeutic approaches, including pharmacological and non-pharmacological strategies.
    Her work bridges clinical insights with translational research, contributing to the development of effective treatment modalities.

🌟 IMPACT AND INFLUENCE

Dr. Wang’s research has had a profound impact on the respiratory medicine field, especially in China. Her findings have been instrumental in shaping clinical guidelines for AECOPD management, benefiting countless patients. She is a sought-after speaker at national and international conferences, sharing her expertise on managing critical respiratory conditions.


📚 ACADEMIC CITES

With a growing body of published works, Dr. Wang has contributed extensively to peer-reviewed journals. Her articles are widely cited, reflecting the significance of her research. She continues to advance the field through collaborations with leading respiratory medicine experts and research teams globally.


🌏 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Na Wang is poised to leave an enduring legacy in respiratory and critical care medicine. Her commitment to:

  1. Advancing knowledge in AECOPD management.
  2. Mentoring future clinicians and researchers.
  3. Pioneering innovative therapeutic approaches.
    ensures that her influence will resonate for years to come. Her future contributions are expected to address emerging challenges in respiratory health and critical care, particularly in aging populations.

🛠 OTHER IMPORTANT TOPICS

💡 MULTIDISCIPLINARY APPROACH

Dr. Wang advocates for collaboration across specialties to improve patient care and advance research. Her work integrates insights from immunology, pharmacology, and critical care practices.


🎓 EDUCATION AND TRAINING INITIATIVES

Dr. Wang is actively involved in teaching and training, emphasizing evidence-based practices to cultivate the next generation of respiratory care professionals. He exemplifies excellence in respiratory and critical care medicine, with a career characterized by impactful research, clinical leadership, and an enduring commitment to improving patient outcomes.


✨CONCLUSION:

Dr. Na Wang stands as a beacon of excellence in Respiratory and Critical Care Medicine, particularly in the management and research of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD). Her journey from a dedicated academic to an influential clinician and researcher reflects her unwavering commitment to advancing healthcare. Through groundbreaking research, impactful teaching, and exemplary clinical practice, Dr. Wang has significantly shaped the field, improving the lives of countless patients and setting a high standard for future contributions.

📊🔬NOTABLE PUBLICATION:
  • The association between chronic obstructive pulmonary disease and autoimmune diseases: a bidirectional Mendelian randomization study
    • Authors: Yu, X., Cheng, X., Lv, L., … Hu, T., Shi, Z.
    • Journal: Frontiers in Medicine
    • Year: 2024

  • A left pulmonary artery sling with left bronchiectasis in an adult patient: A case report and review of literature
    • Authors: Lv, L., Cheng, X., Yu, X., … Liu, J., Shi, Z.
    • Journal: Respirology Case Reports
    • Year: 2023

  • Prolonged elevated heart rate is associated with adverse outcome in severe pulmonary embolism: A retrospective study
    • Authors: Wang, G., Liu, T., Ji, W., … Hu, T., Shi, Z.
    • Journal: International Journal of Cardiology
    • Year: 2024

  • Association between prognostic nutritional index and mortality risk in patients with community-acquired pneumonia: a retrospective study
    • Authors: Wang, G., Wang, N., Liu, T., … Hu, T., Shi, Z.
    • Journal: BMC Pulmonary Medicine
    • Year: 2024

  • Development and validation of a nomogram for assessing survival in acute exacerbation of chronic obstructive pulmonary disease patients
    • Authors: Wang, N., Li, M., Wang, G., … Hu, T., Shi, Z.
    • Journal: BMC Pulmonary Medicine
    • Year: 2024